help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Balasubramanian, K.
Right arrow Articles by Veldhuis, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balasubramanian, K.
Right arrow Articles by Veldhuis, J. D.
Endocrinology Vol. 138, No. 1 433-439
Copyright © 1997 by The Endocrine Society


ARTICLES

Regulation of Porcine Granulosa Cell Steroidogenic Acute Regulatory Protein (StAR) by Insulin-Like Growth Factor I: Synergism with Follicle-Stimulating Hormone or Protein Kinase A Agonist1

K. Balasubramanian2, Holly A. LaVoie, James C. Garmey, Douglas M. Stocco and Johannes D. Veldhuis

Division of Endocrinology and Metabolism (K.B., H.A.L., J.C.G., J.D.V.), Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908; Department of Cell Biology and Biochemistry (D.M.S.), Texas Tech University Health Sciences Center, Lubbock, Texas 79430

Address all correspondence and requests for reprints to: Dr. Johannes D. Veldhuis, Division of Endocrinology and Metabolism, Box 202, Department of Internal Medicine, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The transfer of cholesterol from the outer to the inner mitochondrial membrane, where side-chain cleavage occurs to form pregnenolone, is a crucial event in the regulation of steroidogenesis and recently has been demonstrated to be mediated by steroidogenic acute regulatory protein (StAR). We generated a partial porcine StAR complementary DNA (280 bp) by RT-PCR and used the corresponding antisense riboprobe to quantify the control of StAR gene expression by FSH and insulin-like growth factor I (IGF-I) in hormonally responsive swine granulosa cells, which typically manifest synergistic steroidogenic stimulation by these two dominant intrafollicular regulators. RNase protection assays were implemented to investigate the time course of the actions of FSH (100 ng/ml), IGF-I (100 ng/ml), and FSH plus IGF-I on StAR messenger RNA accumulation in serum-free cultures granulosa cells. Treatment with FSH (1.6-fold) or IGF-I (2.7-fold) alone had a small but consistent stimulatory effect on StAR message accumulation (corrected for 18S ribosomal RNA in each lane) at 48 h, whereas only IGF-I stimulated StAR protein expression (at least 6-fold as assessed by Western blot). Notably, the combined effect of FSH plus IGF-I was strongly synergistic and already significant by 24 h and maximal at 48 h (P < 0.001). Protein kinase A agonist, 8-bromoadenosine 3',5'-cAMP (8-bromo-cAMP) (1 mM) alone elicited a 3.5-fold increase in StAR message and more than 3.7-fold increase in StAR protein expression by 48 h. The combination of IGF-I and FSH or 8-bromo-cAMP evoked a 26- to 40-fold (P < 0.001) synergistic rise in StAR message accumulation. StAR protein also showed a similar synergistic pattern of expression driven by IGF-I and FSH or 8-bromo-cAMP, namely a greater than 56- to 60-fold increase.

In summary, two distinct first messenger regulatory molecules, FSH and IGF-I, interact synergistically to induce amplification of StAR messenger RNA and protein expression in serum-free monolayer cultures of immature (swine) granulosa cells.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
THE FORMATION of pregnenolone from cholesterol, catalyzed by the cholesterol side-chain cleavage enzyme complex (P450scc) that resides in the inner mitochondrial membrane, is the rate-limiting enzymatic step in steroidogenesis (1). This step in the biosynthesis of steroid hormones is stimulated by trophic hormones but is ineffectual in augmenting steroidogenesis unless there is concurrently increased translocation of cholesterol from the outer to the inner mitochondrial membranes (2, 3). Consequently, effective cholesterol transport to the mitochondrial P450scc is believed to be a pivotal locus of steroidogenic regulation. This process is mediated by a short-lived cycloheximide-sensitive protein (1, 2, 3). Considerable evidence now suggests that the steroidogenic acute regulatory protein (StAR), a specific mitochondrial protein, mediates this critical function (4, 5, 6).

Recent cloning and transient transfection studies of the StAR complementary DNA (cDNA) in MA-10 (mouse Leydig tumor) cells showed that StAR expression conferred nearly a 3-fold increase in basal progesterone production compared with control cells transfected with vector alone, thus indicating a direct relationship between StAR expression and steroidogenesis (4, 7). Moreover, StAR messenger RNA (mRNA) and protein expression were acutely induced by trophic hormone stimulation in MA-10 cells (8). Studies on StAR gene expression in ovine corpora lutea showed high concentrations of StAR mRNA, which were stimulated by LH and GH. Furthermore, the physiologically varying luteal concentrations of mRNA encoding StAR were accompanied by corresponding changes in serum concentrations of progesterone (9).

Northern analysis of bovine StAR gene expression showed 3-kilobase pair (kb) and 1.8-kb transcripts, which are highly expressed in corpora lutea compared with adrenal gland, whereas no detectable expression was recorded in granulosa cells isolated from large preovulatory follicles (10). However, Sugawara et al. (11) have reported a major StAR mRNA transcript of 1.6 kb and less abundant transcripts of 4.4 and 7.5 kb in human ovary and testis. Three transcripts of 1.6, 2.7, and 3.4 kb for StAR mRNA have also been detected in MA-10 mouse Leydig tumor cells (8). Cultured human luteinized granulosa cells treated with 8-bromoadenosine 3',5'-cAMP (8-bromo-cAMP) responded with an increase of 3-fold or more in StAR mRNA accumulation at 24 h suggesting the presence of cAMP-responsive elements in StAR gene promoter region (11, 12). Finally, the identification of functionally relevant mutations in the StAR gene cloned from patients suffering from congenital lipoid adrenal hyperplasia associated with markedly impaired adrenal and gonadal steroidogenesis (5) has established the significant role of StAR in human steroidogenesis.

In view of the importance of StAR in basal and hormonally regulated steroidogenesis and the limited knowledge of FSH and growth factor regulation of this gene in gonadal cells, we undertook studies to determine the effects of FSH and/or insulin-like growth factor I (IGF-I) on StAR gene expression. These two trophic molecules are intimately involved in the maturation and differentiation of granulosa cells towards a progesterone-secreting phenotype, which would presumptively require StAR message and protein expression.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Reagents
Ovine FSH (NIDDK oFSH-17) was obtained from the National Hormone and Pituitary Program, NIH (Bethesda MD); 8-bromo-cAMP and porcine insulin from Sigma Chemical Co. (St. Louis, MO); human recombinant IGF-I from Bachem (Torrance, CA); and [32P]UTP from Amersham Corp. (Arlington Heights, IL).

Cell culture
Granulosa cells were isolated from small and medium-sized (1–5 mm) follicles of immature (60–70 kg) swine by fine needle aspiration (13). Cells were washed three times by low speed centrifugation (3000 rpm) in Eagle’s MEM, and approximately 4 x 107 viable granulosa cells were plated in 10-cm culture dishes (Corning, Corning, NY) containing bicarbonate-buffered MEM and initially 3% FCS (GIBCO, Grand Island, NY) to permit cell anchorage. Granulosa cells were allowed to attach to culture dishes for 16–24 h at 37 C and 5% CO2. Following the attachment period, cells were maintained in serum-free MEM supplemented with antibiotics with the indicated treatments for the designated time interval.

RNA isolation
RNA pooled from three to five dishes contributed to each experimental replicate. Total RNA was isolated from harvested cells as previously described (13) using the method of Chirgwin et al. (14). RNA pellets were ethanol precipitated, washed, and resuspended in sterile water, and quantitated spectrophotometrically by absorbance at 260/280 nm in a Spectronics model 601 spectrophotometer.

Mitochondrial protein isolation
Mitochondrial protein pooled from six dishes contributed to each experimental replicate. For protein isolation, granulosa cells were harvested from culture dishes by scraping with a rubber policeman into 5 ml buffer containing 0.25 M sucrose, 10 mM Tris, 0.1 mM EDTA (pH 7.4). Cells were processed immediately or frozen at -70 C for later processing. Cells were homogenized on ice using 20 strokes in a Dounce homogenizer. Lysates were centrifuged at 600 x g for 15 min at 4 C. The supernatant was centrifuged at 10,000 x g for 15 min at 4 C and the resulting pellet resupended in 1 ml ice-cold buffer. A 100-µl aliquot of this was saved for later protein quantitation by using Bio-Rad protein dye reagent (Bio-Rad Laboratories, Hercules, CA). The remaining mitochondrial resuspension was pelleted by centrifugation at 10,000 x g for 15 min at 4 C. The mitochondrial pellet was frozen at -70 C and then lyophilized. Western analysis was performed as previously described using a mouse polyclonal StAR antibody (4) and 300 µg of granulosa cell mitochondrial protein.

Generation of porcine StAR cDNA riboprobe
A partial porcine cDNA sequence was cloned from porcine corpora lutea RNA by RT-PCR. The 280-bp cDNA was amplified using primers corresponding to mouse sequence bases 442–461 and 702–722 (4). RT-PCR was performed using the GENEAMP RNA PCR kit (Perkin-Elmer/Cetus, Norwalk, CT), and a single band of expected size was amplified and purified on low melt agarose gel and extracted on Wizard PCR Prep minicolumns (Promega Corp., Madison, WI). The DNA band was subcloned into the TA PCRII cloning vector (Invitrogen Corp., San Diego, CA) and transformed into competent INV-{alpha}F' strain of Escherichia coli. The insert was sequenced manually by the dideoxynucleotide chain termination method (Sequenase version 2 kit, U.S. Biochemical Corp., Cleveland, OH). Both strands were fully sequenced. The sequence was confirmed by an automated sequencer (Biomolecular Research Facility, University of Virginia, Charlottesville, VA). Two separate tissue preparations pooled from three or more animals were analyzed by PCR and independently sequenced to confirm reproducibility.

Solution hybridization/RNase protection assay
RNase protection assays were performed using the RPA II kit (Ambion, Austin, TX). The StAR antisense riboprobe (complementary RNA), approximately 376 bases in length, was transcribed using the Maxiscript in vitro transcription kit (Ambion). Before transcription, the DNA template was linearized with EcoRV. Transcription was carried out for 1 h at room temperature using 1 µg DNA template with [32P]UTP and SP6 polymerase. Large quantities of very low specific activity (2500 dpm/µg) human 18S ribosomal RNA antisense riboprobe were synthesized using Ambion’s pT7 RNA 18S template, T7 polymerase, and the MEGAscript in vitro transcription kit. Labeled riboprobes were purified using Sephadex G-50 minispin columns (Worthington Biochemical Corp., Freehold, NJ). Preliminary experiments were performed to determine saturating quantities of each riboprobe used in subsequent experiments. Total RNA (10 µg) from granulosa cells was resuspended in hybridization buffer containing saturating concentrations of high specific activity StAR riboprobe and low specific activity 18S riboprobe. The mixture was heated to 90 C for 4 min, and samples were hybridized for 18 h at 45 C. Subsequently, samples were treated with RNase A/T1 mixture for 30 min at 37 C, precipitated, and resuspended in formamide-containing gel loading buffer, and run on 8% polyacrylamide-8 M urea gels. Gels were exposed overnight and up to three days to Fuji RX film at -70 C with intensifying screens. Protected RNA bands were quantitated by laser densitometry using ImageQuant software and densitometer (Molecular Dynamics, Sunnyvale, CA).

Other analytical methods
Progesterone concentrations in culture medium were measured by RIA using antibody-coated tubes manufactured by ICN Biomedicals (Costa Mesa, CA). The RIA has a sensitivity of 0.15 ng/ml and less than 1% cross-reactivity with other relevant steroid hormones, including estradiol and 17-hydroxyprogesterone (13).

Statistical methods
Unless noted, all data are presented as mean ± SEM of three or more independent experiments using separate batches of 200–300 ovaries to confirm the reproducibility of results. To adjust for nonhomogeneous variances in the StAR message data, values were transformed by multiplying by a factor of 10 and converting each to a natural log value and subjecting these values to ANOVA. Treatments were evaluated post hoc by the Tukey HSD multiple comparison test. Time course mRNA data were likewise log-transformed and submitted to regression analysis. Progesterone data were used untransformed for ANOVA followed by the Tukey HSD test (15). Because control StAR protein values were not detectable in two out of three experiments, treatment protein values could not be normalized for control in each experiment, and therefore were not statistically analyzed. Fold increases (relative to control) in protein were calculated from the mean values for the three experiments.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The PCR cloning of the porcine StAR cDNA was verified by multiple dideoxy chain termination sequencing and the sequence has been submitted to Genbank (accession no. U72195). The full length porcine StAR cDNA has recently been submitted to Genbank by another laboratory; all clones of our partial cDNA show a GC transposition at bases 170 and 171 of our sequence when compared with the full length clone. The nucleotide sequence encoding the 280-bp cDNA was determined to be 89%, 91%, and 87% identical to the comparable regions in murine (4), ovine (9), and human (12) StAR cDNA, respectively.

The time course of the actions of FSH, IGF-I, and FSH plus IGF-I on StAR mRNA accumulation was investigated by culturing granulosa cells for 6, 12, 24, and 48 h in the presence of serum-free medium alone, FSH (100 ng/ml), IGF-I (100 ng/ml), or FSH plus IGF-I. The time course was initiated after cell attachment; then, cells were maintained in serum-free medium for a total of 48 h. Six, 12, 24, and 48 h before termination of this incubation, the indicated effectors or vehicle were added to the cultures.

All hormone treatments produced significant time-dependent stimulation of progesterone production, demonstrating the functional responsiveness of these immature granulosa cells to these hormones (Fig. 1AGo). As shown in Fig. 1BGo, hybridization with [32P]-labeled StAR complementary RNA, followed by RNase digestion and PAGE, resulted in protected StAR and 18S ribosomal RNA bands corresponding to sizes of approximately 280 and a 70/80 bp doublet, respectively. Figure 1CGo graphically summarizes the quantitative densitometry results of these replicated studies. Treatment with FSH or IGF-I alone had only a small effect on StAR message accumulation at any time during the 48 h studied. However, each hormone (FSH, three of three experiments; IGF-I, five of five experiments) alone produced a consistent small increase (1.6- to 2.7-fold) in StAR mRNA at 48 h. Moreover, the combined effect of FSH plus IGF-I was significant by 24 h and maximal at 48 h (P < 0.001).



View larger version (33K):
[in this window]
[in a new window]
 
Figure 1. A, Histogram summary of time-course of progesterone accumulation (ng/ml) in porcine granulosa cells treated with vehicle (control), FSH (100 ng/ml), IGF-I (100 ng/ml), or FSH plus IGF-I. Monolayer cultures were incubated for 48 h after initial attachment period. Cells were treated with or without hormones for the last 6, 12, 24, or 48 h of culture. Data are the mean ± SEM from two to six experiments. *, Treatments significantly greater than control values at any time point, P <= 0.0001. B, Representative autoradiogram showing time course experiments for StAR mRNA accumulation in porcine granulosa cells treated with vehicle (C), FSH, IGF-I, or FSH plus IGF-I. Ten-microgram aliquots of granulosa cell total RNA were subjected to RNase protection assay as described in Materials and Methods. Protected bands corresponding to StAR mRNA (280 bp) and 18S rRNA (70 and 80 bp doublet) are indicated on the right. C, Histogram summary of time-course experiments for StAR mRNA accumulation in porcine granulosa cells. Legends same as in panel A. Data are the mean ± SEM from two to three experiments and represent optical density units for StAR mRNA normalized to constitutively expressed 18S rRNA and corrected for time = 0 (unstimulated) control. The inset shows the log-transformed linear regressions of control and FSH plus IGF-I data. The slope of each regression line ± SEM is indicated. The Control response did not change significantly over time, P = 0.81, whereas the FSH plus IGF-I treated cells showed a significant time-dependent increase in StAR mRNA accumulation, P = 0.001.

 
To further assess whether the synergistic interaction of FSH and IGF-I could be exerted in part at or after cAMP generation (post-cAMP effect), a stable chemical analog of cAMP, 8-bromo-cAMP, was used to stimulate the protein kinase A (PKA) signal transduction pathway without activating the FSH receptor or adenylate cyclase. Figure 2AGo gives a representative autoradiogram showing the effects of 48 h treatment with FSH (100 ng/ml), IGF-I (100 ng/ml), 8-bromo-cAMP (1 mM) and their relevant combinations on granulosa cell StAR mRNA accumulation. Treatment of granulosa cells with 8-bromo-cAMP alone (like FSH) had only a small stimulatory effect on mRNA levels encoding StAR (3.5-fold) (Fig. 2BGo). However, in three experiments, when combined with IGF-I (100 ng/ml), the synergistic effect of the cAMP agonist (40-fold) was comparable with that observed in FSH plus IGF-I treated cells (26-fold). Granulosa cells were steroidogenically responsive to 8-bromo-cAMP during the 48 h culture period with a mean progesterone accumulation (ng/ml) of 409 ± 13 for 8-bromo-cAMP alone and 512 ± 77 when combined with IGF-I.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 2. A, Representative autoradiogram showing the effects of 48 h treatment with FSH, IGF-I, 8-bromo-cAMP and their combinations on specific porcine granulosa-cell StAR mRNA accumulation. Granulosa cells were treated for 48 h in serum-free medium with vehicle (C), FSH (100 ng/ml), IGF-I (100 ng/ml), FSH plus IGF-I, 8-bromo-cAMP (1 mM) and 8-bromo-cAMP plus IGF-I after an initial attachment period. Ten-microgram aliquots of total RNA were subjected to RNase protection assay as described in Materials and Methods. Riboprobes were carried through the assay in the presence of nontarget yeast RNA and were subsequently incubated with (+) and without (-) RNases. Protected fragments are indicated on the right. B, Summary of StAR mRNA accumulation following 48 h treatment with vehicle (C), FSH, IGF-I, 8-bromo-cAMP, and their combinations. Data are mean ± SEM of optical density units of StAR mRNA normalized to 18S rRNA and expressed as fold increases relative to the control value for three to eight experiments. *, Treatments significantly greater than C, FSH, IGF-I, and 8-bromo-cAMP, P <= 0.001, by Tukey HSD multiple comparison test. Other treatments were not significantly different from control by Tukey HSD but showed consistent increases relative to control in all experiments.

 
The immunoblot analysis of StAR protein expressed in granulosa cells treated with vehicle, FSH, IGF-I, 8-bromo-cAMP and their combinations for 48 h is depicted in Fig. 3Go. Similar to StAR mRNA accumulation, StAR protein expression was markedly increased in FSH plus IGF-I and 8-bromo-cAMP plus IGF-I treated granulosa cells more than 56- to 60-fold for the three experiments considered together, whereas IGF-I and 8-bromo-cAMP alone elicited small increases (at least 6- and 3.7-fold, respectively), and FSH did not increase protein levels. Increases were at least the "fold" values indicated because control lanes were undetectable in two of three experiments. These data demonstrate that StAR mRNA, protein, and progesterone biosynthesis are induced concomitantly and that this likely occurs in part via a cAMP-mediated mechanism, wherein FSH or cAMP synergize with IGF-I actions.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 3. Summary of immunoblot analysis of StAR protein accumulation in porcine granulosa cells following 48 h treatment with vehicle (C), FSH, IGF-I, 8-bromo-cAMP, or their combinations (at the doses given in Fig. 2AGo). Mitochondrial protein (300 µg) was analyzed in each sample. Mitochondria were isolated from granulosa cells as described in Materials and Methods. Data are optical density units (IOD) of StAR protein for three individual experiments. ND, means StAR protein was not detectable. Amplitudes of IOD may vary with exposure time between blots, thus all three experiments are presented to show within experiment responses.

 
Because high concentrations of insulin can mimic IGF-I action in swine granulosa cells presumptively through type I receptors, insulin-treated granulosa cells were assessed for StAR mRNA expression. Insulin (3 µg/ml) also increased StAR message by 5.2 ± 1.2-fold relative to untreated control (n = 3 experiments).


    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
StAR protein is a novel pivotal factor required for acute responses of gonadal and adrenal steroidogenic cells to trophic hormone stimulation. The present investigation extends this theme to the actions of FSH and/or IGF-I, two major first-messenger molecules involved in maturation and differentiation of granulosa cells.

As mentioned above, Northern analysis has revealed two or three transcripts of StAR in other species. RNase protection analysis with our porcine probe, which spans the equivalent of exons 4 and 5 in the corresponding sequence of the mouse cDNA, would not detect transcripts that differ at the 3' or 5' ends but is a quantitative estimate of total StAR message coding sequence. Recently, Northern analysis using a mouse StAR cDNA has revealed two transcripts in porcine ovary and testes of approximately 1.5 and 2.8 kb, with the larger transcript being more predominant (16). It is not known whether trophic hormones or growth factors can differentially regulate the transcripts of the StAR message.

An acute action of trophic hormones on steroidogenic cells is to mobilize and deliver cholesterol, the precursor substrate for steroid hormone biosynthesis, to the mitochondrial inner membrane, where it is metabolized to pregnenolone by the cytochrome P450 cholesterol side-chain cleavage enzyme complex (3, 17). Early studies indicated that puromycin or cycloheximide, inhibitors of protein synthesis, blocked trophic hormone-stimulated acute steroidogenesis without affecting the activity of P450scc or the delivery of cholesterol to the outer mitochondrial membrane (18, 19, 20). Such experiments suggested the involvement of newly synthesized protein in the translocation of cholesterol to the inner mitochondrial membrane (21). Recently, the StAR gene was cloned as a plausible mediator of this process (4).

Hormonally untreated sparingly differentiated pig granulosa cells revealed little detectable basal expression of StAR mRNA and protein in the present study. This finding is consistent with recent observations in unstimulated bovine granulosa cells (10). Swine granulosa cells treated with PKA agonist, 8-bromo-cAMP, or IGF-I alone for 48 h showed an average of 3.5- or 2.7-fold increase in StAR mRNA accumulation, respectively, compared with untreated cells. The combined actions of 8-bromo-cAMP and IGF-I yielded a 40-fold increase in StAR message indicating prominent synergism in the regulation of this gene transcript. In accordance with the present results, recently Sugawara et al. (11) also reported stimulatory effects of cAMP analogue treatment (for 24 h) on StAR message expression in luteinized human granulosa cells. Importantly, in the present study immunoblot analysis of the StAR protein also disclosed prominent synergistic actions of IGF-I plus FSH or 8-bromo-cAMP, thus indicating effective StAR mRNA translation as well.

Many actions of gonadotropic hormones, including FSH, on steroidogenic cells are mediated at least in part by cAMP activation of PKA (22, 23). Thus we used the PKA agonist, 8-bromo-cAMP to determine if it could mimic the FSH effect on StAR message and protein expression. In the present investigation, 48 h treatment of primary cultures of porcine granulosa cells with FSH, 8-bromo-cAMP, and IGF-I had modest individual effects on StAR message accumulation when compared with the combination of FSH or 8-bromo-cAMP with IGF-I. The combination of either PKA activator with IGF-I evoked a marked time-dependent synergism. Qualitatively similar synergism was reported in porcine granulosa cells with respect to 3-hydroxy-3-methyl glutaryl coenzyme A (HMG-CoA) reductase message accumulation (24), although the magnitudes of these interactions varied. The mechanisms which underlie this synergism putatively involve FSH’s stimulation of cAMP and the PKA pathway on the one hand, and IGF’s activation of its receptor tyrosine kinase and associated signals on the other hand. Where these signaling pathways interact to ultimately increase expression of the StAR gene transcript is not yet known. However, this interaction is likely to be of major physiological importance because the intrafollicullar presence of immunoreactive IGF-I, its receptor, binding proteins, and trophic effects of IGF’s on ovarian cells have all been documented (25, 26, 27, 28, 29). IGF-I binds and activates an intrinsic tyrosine kinase activity of high-affinity, saturable, low-capacity receptors in porcine granulosa cells (30, 31). Further, FSH stimulates IGF-I production by and binding to granulosa cells (25, 32). Although in some species such as the pig IGF-I is able to stimulate progesterone biosynthesis alone, in many species it markedly enhances FSH-stimulated steroidogenesis, granulosa-cell cytodifferentiation, and LH receptor formation in part by increasing FSH-induced cAMP accumulation as well as via actions at post-cAMP loci (28, 33, 34, 35, 36, 37). Therefore, the synergistic influence of FSH and IGF-I on StAR mRNA accumulation could reflect stimulatory interactions of these hormones at one or more levels, such as hormone binding, activation of second messengers, and distal intracellular cascades of molecular events that control specific gene expression in differentiating granulosa cells.

Interestingly, progesterone concentrations in our FSH or IGF-I alone treated granulosa cell cultures increased significantly in 48 h, whereas StAR mRNA accumulation or StAR protein expression only rose to a small extent. This is in contrast to time-course studies done in MA-10 Leydig tumor cells where 8-bromo-cAMP induced steroid production that paralleled StAR expression (4). The failure to increase progesterone synthesis in vitro equivalently to StAR transcripts may reflect the need of porcine granulosa cells for lipoprotein-borne cholesterol substrate to maximize steroidogenesis in serum-free conditions. In this regard, the FSH plus IGF-I synergism also was expressed at the level of mRNA and protein, but not progesterone production, at least under the present serum-free and lipoprotein-free in vitro culture conditions. Indeed, addition of swine or human low density lipoprotein allows remarkable (100-fold) FSH/IGF-I synergism in progesterone production by these cells (37). Relatively low stability of StAR message or protein in FSH or IGF-I treated cells compared with FSH plus IGF-I treated cells could also account for our findings. Whether enhanced StAR mRNA accumulation observed in the present studies is the direct consequence of increased transcription, heightened message stability, or both, remains to be established. For example, the increase in StAR mRNA accumulation in FSH and IGF-I treated swine granulosa cells may result from increased StAR gene promoter activity. In the porcine P450scc enzyme promoter, these two hormones promote transcription via a common site in the 5'-flanking region of the gene (38). In addition, like the P450scc enzyme and other steroid hydroxylases, a SF-1 site(s) is present in both the murine and human StAR promoters and contributes to transcriptional regulation (8, 12). Further investigation of the regulatory mechanisms of StAR gene expression will be necessary to unravel the molecular messengers that mediate FSH and IGF-I’s synergism in granulosa cells.

In conclusion, StAR gene expression in primary cultures of porcine granulosa cells is stimulated above control levels by FSH, 8-bromo-cAMP, or IGF-I individually, but 26- to 40-fold by the combined trophic effects of IGF-I and FSH (or 8-bromo-cAMP), thereby evincing a marked synergism. Similar results showing StAR mRNA and protein accumulation in FSH plus IGF-I or 8-bromo-cAMP plus IGF-I treated granulosa cells imply that IGF-I’s facilitation of FSH action on StAR gene expression may be mediated through activation of the distal PKA pathway. The synergistic regulation by FSH and IGF-I of StAR message and protein expression may prepare granulosa cells for the increased steroidogenic demand imposed during the later stages of granulosa-luteal cell differentiation.


    Footnotes
 
1 This work was supported by NIH Grants HD-16806 and HD-16393 (to J.D.V.), HD-17481 (to D.M.S.), HD-07382 and HD-08019 (to H.A.L.), P30-HD-28934 (Center for Cellular and Molecular Studies in Reproduction) and DBT No. BT/MP/03/019/95 Government of India (to K.B.). Back

2 On leave from the Department of Endocrinology, University of Madras, Taramani, Madras, India 600 113. Back

Received August 19, 1996.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Miller WL 1988 Molecular biology of steroid hormone synthesis. Endocr Rev 9:295–318[CrossRef][Medline]
  2. Simpson ER, McCarthy JL, Peterson JA 1978 Evidence that the cycloheximide-sensitive site of adrenocorticotrophic hormone action is in the mitochondrion. J Biol Chem 253:3135–3139[Free Full Text]
  3. Toaff ME, Strauss JF, III, Flickinger GL, Shattil SL 1979 Relationship of cholesterol supply to luteal mitochondrial steroid synthesis. J Biol Chem 254:3977–3982[Free Full Text]
  4. Clark BJ, Wells J, King SB, Stocco DM 1994 The purification, cloning and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells-Characterization of the steroidogenic acute regulatory protein (StAR). J Biol Chem 269:28314–28322[Abstract/Free Full Text]
  5. Lin D, Sugawara T, Strauss III JF, Clark BJ, Stocco DM, Saenger P, Rogol A, Miller WL 1995 Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267:1828–1831[Abstract/Free Full Text]
  6. Stocco DM, Clark BJ 1996 Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 17:221–244[CrossRef][Medline]
  7. Clark BJ, Stocco DM 1995 Expression of the steroidogenic acute regulatory(StAR) protein: a novel LH-induced mitochondrial protein required for the acute regulation of steroidogenesis in the mouse Leydig tumor cells. Endo Res 21:243–257
  8. Clark BJ, Soo SC, Caron KM, Ikeda Y, Parker KL, Stocco DM 1995 Hormonal and developmental regulation of the steroidogenic acute regulatory protein. Mol Endocrinol 9:1346–1355[Abstract]
  9. Juengel JL, Meberg BM, Turzillo AM, Nett TM, Niswender GD 1995 Hormonal regulation of messenger ribonucleic acid encoding steroidogenic acute regulatory protein in ovine corpora lutea. Endocrinology 136:5423–5429[Abstract]
  10. Hartung S, Rust W, Balvers M, Ivell R 1995 Molecular cloning and in vivo expression of the bovine steroidogenic acute regulatory protein. Biochem Biophys Res Commun 215:646–653[CrossRef][Medline]
  11. Sugawara T, Holt JA, Driscoll D, Strauss III JF, Lin D, Miller WL, Patterson D, Clancy KP, Hart IM, Clark BJ, Stocco DM 1995 Human steroidogenic acute regulatory protein: functional activity in COS-1 cells, tissue-specific expression, and mapping of the structural gene to 8p 11.2 and a pseudogene to chromosome 13. Proc Natl Acad Sci USA 92:4778–4782[Abstract/Free Full Text]
  12. Sugawara T, Lin D, Holt JA, Martin KO Javitt NB, Miller WL, Strauss III JF 1995 Structure of the human steroidogenic acute regulatory protein (StAR) gene: StAR stimulates mitochondrial cholesterol 27-hydroxylase activity. Biochemistry 34:12506–12512[CrossRef][Medline]
  13. Urban RJ, Garmey JC, Shupnik MA, Veldhuis JD 1990 Insulin-like growth factor type I increases concentrations of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage enzyme in primary cultures of porcine granulosa cells. Endocrinology 127:2481–2488[Abstract]
  14. Chirgwin JM, Przybyla AE, MacDonald R, Rutter WJ 1979 Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294–5299[CrossRef][Medline]
  15. Winer BJ 1971 Statistical principles in experimental design, ed 2. McGraw-Hill, New York, pp 232–250
  16. Pescador N, Houde A, Men T-Y, Dobias M, and Murphy BD 1996 Steroidogenic acute regulatory protein (StAR) mRNA in porcine ovary and testis, and regulation in granulosa cells. Biol Reprod [Suppl 1] 54:164 (Abstract)
  17. Jefcoate CR, DiBartolomeis MJ, Williams CA, McNamara BC 1987 ACTH regulation of cholesterol movement in isolated adrenal cells. J Steroid Biochem 27:721–729[CrossRef][Medline]
  18. Ferguson JJ 1963 Protein synthesis and adrenocorticotropin responsiveness. J Biol Chem 238:2754–2759[Free Full Text]
  19. Garren LD, Ney RL, Davis WW 1965 Studies on the role of protein synthesis in the regulation of corticosterone production by adrenocorticotropic hormone in vivo. Proc Natl Acad Sci USA 53:1443–1450[Free Full Text]
  20. Privalle CT, Crivello JF, Jefcoate CR 1983 Regulation of intramitochondrial cholesterol transfer to side-chain cleavage cytochrome P-450 in rat adrenal gland. Proc Natl Acad Sci USA 80:702–706[Abstract/Free Full Text]
  21. Krueger RJ, Orme-Johnson NR 1983 Acute adrenal hormone stimulation of adrenal corticosteroidogenesis. Discovery of a rapidly induced protein. J Biol Chem 257:10159–10167[Abstract/Free Full Text]
  22. Pon LA, Orme-Johnson NR 1986 Acute stimulation of steroidogenesis in corpus luteum and adrenal cortex by peptide hormones. Rapid induction of a similar protein in both tissues. J Biol Chem 261:6594–6599[Abstract/Free Full Text]
  23. Urban RJ, Garmey JC, Shupnik MA, Veldhuis JD 1991 Follicle-stimulating hormone increases concentrations of messenger ribonucleic acid encoding cytochrome P450 cholesterol side-chain cleavage enzyme in primary cultures of porcine granulosa cells. Endocrinology 128:2000–2007[Abstract]
  24. Maitra A, LaVoie HA, Day RN, Garmey JC, Veldhuis JD 1995 Regulation of porcine granulosa cell 3-hydroxy-3-methylglutaryl coenzyme-A reductase by insulin and insulin-like growth factor-I: synergism with follicle stimulating hormone or protein kinase A agonist. Endocrinology 136:5111–5117[Abstract]
  25. Hsu CJ, Hammond JM 1987 Gonadotropins and estradiol stimulate immunoreactive insulin-like growth factor-I production by porcine granulosa cells in vitro. Endocrinology 120:198–207[Abstract]
  26. Hammond JM, Veldhuis JD, Seale TW, Rechler MM 1982 Intraovarian regulation of granulosa cell replication. In: Channing CP, Segal SJ (eds) Intraovarian control mechanisms. Plenum Press, New York, pp 341–356
  27. Hammond JM, Yoshida K, Veldhuis JD, Rechler MM, Knight AB 1983 Intrafollicular role of somatomedins: comparison with effects of insulin In: Greenwald GS, Terranova PF (eds) Factors regulating ovarian function. Raven Press, New York pp 197–201
  28. Baranao JLS, Hammond JM 1984 Comparative effects of insulin and insulin-like growth factors on DNA synthesis and differentiation of porcine granulosa cells. Biochem Biophys Res Commun 124:484–490[CrossRef][Medline]
  29. Hsu CJ, Hammond JM 1987 Concomitant effects of growth hormone on secretion of insulin-like growth factor-I and progesterone by cultured porcine granulosa cells. Endocrinology 121:1343–1348[Abstract]
  30. Veldhuis JD, Furlanetto RW 1985 Trophic actions of human somatomedin C/insulin-like growth factor-I on ovarian cells: in vitro studies with swine granulosa cells. Endocrinology 116:1235–1242[Abstract]
  31. Rechler MM, Nissley SP 1986 Insulin-like growth factor (IGF)/somatomedin receptor subtypes: structure, function and relationships to insulin receptors and IGF carrier proteins. Horm Res 24:152–159[Medline]
  32. Adashi EY, Resnick CE, Svoboda ME, Van Wyk JJ 1986 Follicle stimulating hormone enhances somatomedin C binding to cultured rat granulosa cells. J Biol Chem 261:3923–3926[Abstract/Free Full Text]
  33. Adashi EY, Resnick CE, Svoboda ME, Van Wyk JJ 1984 A novel role for somatomedin-C in the cytodifferentiation of the ovarian granulosa cell. Endocrinology 115:1227–1229[Abstract]
  34. Veldhuis JD, Demers LM 1985 A role for somatomedin-C as a differentiating hormone and amplifier of hormone action on ovarian cells: Studies with synthetically pure human somatomedin-C and swine granulosa cells. Biochem Biophys Res Commun 130:234–240[CrossRef][Medline]
  35. Adashi EY, Resnick CE, Svoboda ME, Van Wyk JJ 1986 Somatomedin-C as an amplifier of follicle stimulating hormone action: Enhanced accumulation of adenosine 3',5',-monophosphate. Endocrinology 118:149–155[Abstract]
  36. Adashi EY, Resnick CE, Svoboda ME, Van Wyk JJ 1985 Somatomedin-C synergizes with follicle-stimulating hormone in the acquisition of progestin biosynthetic capacity by cultured rat granulosa cells. Endocrinology 116:2135–2142[Abstract]
  37. Veldhuis JD, Rodgers RJ 1987 Mechanisms subserving the steroidogenic synergism between follicle stimulating hormone and insulin-like growth factor (somatomedin-C): alterations in cellular sterol metabolism in swine granulosa cells. J Biol Chem 262:7658–7664[Abstract/Free Full Text]
  38. Urban RJ, Shupnik MA, Bodenburg YH 1994 Insulin-like growth factor-I increases expression of the porcine P-450 cholesterol side chain cleavage gene through a GC-rich domain. J Biol Chem 265:22392–22401[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
EndocrinologyHome page
Y.-J. Chen, M.-T. Lee, H.-C. Yao, P.-W. Hsiao, F.-C. Ke, and J.-J. Hwang
Crucial Role of Estrogen Receptor-{alpha} Interaction with Transcription Coregulators in Follicle-Stimulating Hormone and Transforming Growth Factor {beta}1 Up-Regulation of Steroidogenesis in Rat Ovarian Granulosa Cells
Endocrinology, September 1, 2008; 149(9): 4658 - 4668.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Seto-Young, D. Avtanski, M. Strizhevsky, G. Parikh, P. Patel, J. Kaplun, K. Holcomb, Z. Rosenwaks, and L. Poretsky
Interactions among Peroxisome Proliferator Activated Receptor-{gamma}, Insulin Signaling Pathways, and Steroidogenic Acute Regulatory Protein in Human Ovarian Cells
J. Clin. Endocrinol. Metab., June 1, 2007; 92(6): 2232 - 2239.
[Abstract] [Full Text] [PDF]


Home page
J EndocrinolHome page
P. R Manna, Y. Jo, and D. M Stocco
Regulation of Leydig cell steroidogenesis by extracellular signal-regulated kinase 1/2: role of protein kinase A and protein kinase C signaling
J. Endocrinol., April 1, 2007; 193(1): 53 - 63.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
P. R Manna, S. P Chandrala, Y. Jo, and D. M Stocco
cAMP-independent signaling regulates steroidogenesis in mouse Leydig cells in the absence of StAR phosphorylation.
J. Mol. Endocrinol., August 1, 2006; 37(1): 81 - 95.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. Campbell, J. Dickey, B. Beckman, G. Young, A. Pierce, H. Fukada, and P. Swanson
Previtellogenic Oocyte Growth in Salmon: Relationships among Body Growth, Plasma Insulin-Like Growth Factor-1, Estradiol-17beta, Follicle-Stimulating Hormone and Expression of Ovarian Genes for Insulin-Like Growth Factors, Steroidogenic-Acute Regulatory Protein and Receptors for Gonadotropins, Growth Hormone, and Somatolactin
Biol Reprod, July 1, 2006; 75(1): 34 - 44.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. Rusovici, Y. Y. Hui, and H. A. LaVoie
Epidermal Growth Factor-Mediated Inhibition of Follicle-Stimulating Hormone-Stimulated StAR Gene Expression in Porcine Granulosa Cells Is Associated with Reduced Histone H3 Acetylation
Biol Reprod, April 1, 2005; 72(4): 862 - 871.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
H. A. LaVoie, D. Singh, and Y. Y. Hui
Concerted Regulation of the Porcine Steroidogenic Acute Regulatory Protein Gene Promoter Activity by Follicle-Stimulating Hormone and Insulin-Like Growth Factor I in Granulosa Cells Involves GATA-4 and CCAAT/Enhancer Binding Protein {beta}
Endocrinology, July 1, 2004; 145(7): 3122 - 3134.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Sugawara, H. Shimizu, N. Hoshi, A. Nakajima, and S. Fujimoto
Steroidogenic Acute Regulatory Protein-binding Protein Cloned by a Yeast Two-hybrid System
J. Biol. Chem., October 24, 2003; 278(43): 42487 - 42494.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
C. Gillio-Meina, Y. Y. Hui, and H. A. LaVoie
GATA-4 and GATA-6 Transcription Factors: Expression, Immunohistochemical Localization, and Possible Function in the Porcine Ovary
Biol Reprod, February 1, 2003; 68(2): 412 - 422.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
D. Zaczek, J. Hammond, L. Suen, S. Wandji, D. Service, A. Bartke, V. Chandrashekar, K. Coschigano, and J. Kopchick
Impact of Growth Hormone Resistance on Female Reproductive Function: New Insights from Growth Hormone Receptor Knockout Mice
Biol Reprod, October 1, 2002; 67(4): 1115 - 1124.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
S. Eimerl and J. Orly
Regulation of Steroidogenic Genes by Insulin-Like Growth Factor-1 and Follicle-Stimulating Hormone: Differential Responses of Cytochrome P450 Side-Chain Cleavage, Steroidogenic Acute Regulatory Protein, and 3{beta}-Hydroxysteroid Dehydrogenase/Isomerase in Rat Granulosa Cells
Biol Reprod, September 1, 2002; 67(3): 900 - 910.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. L. Johnson and J. T. Bridgham
Regulation of Steroidogenic Acute Regulatory Protein and Luteinizing Hormone Receptor Messenger Ribonucleic Acid in Hen Granulosa Cells
Endocrinology, July 1, 2001; 142(7): 3116 - 3124.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. F. Palter, A. B. Tavares, A. Hourvitz, J. D. Veldhuis, and E. Y. Adashi
Are Estrogens of Import to Primate/Human Ovarian Folliculogenesis?
Endocr. Rev., June 1, 2001; 22(3): 389 - 424.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
T.-J. Huang and P. Shirley Li
Dexamethasone Inhibits Luteinizing Hormone-Induced Synthesis of Steroidogenic Acute Regulatory Protein in Cultured Rat Preovulatory Follicles
Biol Reprod, January 1, 2001; 64(1): 163 - 170.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
N. Sekar, H. A. LaVoie, and J. D. Veldhuis
Concerted Regulation of Steroidogenic Acute Regulatory Gene Expression by Luteinizing Hormone and Insulin (or Insulin-Like Growth Factor I) in Primary Cultures of Porcine Granulosa-Luteal Cells
Endocrinology, November 1, 2000; 141(11): 3983 - 3992.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. Zhang, J. C. Garmey, and J. D. Veldhuis
Interactive Stimulation by Luteinizing Hormone and Insulin of the Steroidogenic Acute Regulatory (StAR) Protein and 17{alpha}-Hydroxylase/17, 20-Lyase (CYP17) Genes in Porcine Theca Cells
Endocrinology, August 1, 2000; 141(8): 2735 - 2742.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. C. L. Jayes, R. N. Day, J. C. Garmey, R. J. Urban, G. Zhang, and J. D. Veldhuis
Calcium Ions Positively Modulate Follicle-Stimulating Hormone- and Exogenous Cyclic 3',5'-Adenosine Monophosphate-Driven Transcription of the P450scc Gene in Porcine Granulosa Cells
Endocrinology, July 1, 2000; 141(7): 2377 - 2384.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
F. Belin, G. Goudet, G. Duchamp, and N. Gérard
Intrafollicular Concentrations of Steroids and Steroidogenic Enzymes in Relation to Follicular Development in the Mare
Biol Reprod, May 1, 2000; 62(5): 1335 - 1343.
[Abstract] [Full Text]


Home page
Mol Hum ReprodHome page
L. Devoto, L. K. Christenson, J. M. McAllister, A. Makrigiannakis, and J. F. Strauss III
Insulin and insulin-like growth factor-I and- II modulate human granulosa-lutein cell steroidogenesis: enhancement of steroidogenic acute regulatory protein (StAR) expression
Mol. Hum. Reprod., November 1, 1999; 5(11): 1003 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
N. Pescador, D. M. Stocco, and B. D. Murphy
Growth Factor Modulation of Steroidogenic Acute Regulatory Protein and Luteinization in the Pig Ovary
Biol Reprod, June 1, 1999; 60(6): 1453 - 1461.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. Kanzaki and P. L. Morris
Growth Hormone Regulates Steroidogenic Acute Regulatory Protein Expression and Steroidogenesis in Leydig Cell Progenitors
Endocrinology, April 1, 1999; 140(4): 1681 - 1686.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
R. Mamluk, Y. Greber, and R. Meidan
Hormonal Regulation of Messenger Ribonucleic Acid Expression for Steroidogenic Factor-1, Steroidogenic Acute Regulatory Protein, and Cytochrome P450 Side-Chain Cleavage in Bovine Luteal Cells
Biol Reprod, March 1, 1999; 60(3): 628 - 634.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
A. Kerban, D. Boerboom, and J. Sirois
Human Chorionic Gonadotropin Induces an Inverse Regulation of Steroidogenic Acute Regulatory Protein Messenger Ribonucleic Acid in Theca Interna and Granulosa Cells of Equine Preovulatory Follicles
Endocrinology, February 1, 1999; 140(2): 667 - 674.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
H. A. LaVoie, J. C. Garmey, and J. D. Veldhuis
Mechanisms of Insulin-Like Growth Factor I Augmentation of Follicle-Stimulating Hormone-Induced Porcine Steroidogenic Acute Regulatory Protein Gene Promoter Activity in Granulosa Cells
Endocrinology, January 1, 1999; 140(1): 146 - 153.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
C. Mauduit, F. Gasnier, C. Rey, M.-A. Chauvin, D. M. Stocco, P. Louisot, and M. Benahmed
Tumor Necrosis Factor-{alpha} Inhibits Leydig Cell Steroidogenesis through a Decrease in Steroidogenic Acute Regulatory Protein Expression
Endocrinology, June 1, 1998; 139(6): 2863 - 2868.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Amsterdam and N. Selvaraj
Control of Differentiation, Transformation, and Apop